Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

Background/Aims New prognostic markers are needed to identify patients with hepatocellular carcinoma (HCC) who carry a worse prognosis. Ultra-low-pass whole-genome sequencing (ULP-WGS) (≤0.5× coverage) of cell-free DNA (cfDNA) has emerged as a low-cost promising tool to assess both circulating tumor...

Full description

Bibliographic Details
Main Authors: Miguel Sogbe, Idoia Bilbao, Francesco P. Marchese, Jon Zazpe, Annarosaria De Vito, Marta Pozuelo, Delia D’Avola, Mercedes Iñarrairaegui, Carmen Berasain, Maria Arechederra, Josepmaria Argemi, Bruno Sangro
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2024-04-01
Series:Clinical and Molecular Hepatology
Subjects:
liver cancer
liquid biopsy
copy number alterations
prognosis
biomarkers
Online Access:http://e-cmh.org/upload/pdf/cmh-2023-0426.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2023-0426.pdf

Similar Items